ANN HENLEY: Open Payments
NPI 1982877809 · FENTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,357 in 119 payments from 22 companies in 2025. Trend: 2023 $2,016 · 2024 $2,593 · 2025 $2,357
Food & beverage: $2,357
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $456 |
| AstraZeneca Pharmaceuticals LP | 13 | $409 |
| PFIZER INC. | 18 | $299 |
| ABBVIE INC. | 25 | $228 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $158 |
| Axsome Therapeutics, Inc. | 2 | $142 |
| Otsuka America Pharmaceutical, Inc. | 5 | $119 |
| Exact Sciences Corporation | 4 | $101 |
| Aimmune Therapeutics, Inc. | 4 | $68 |
| Lilly USA, LLC | 4 | $67 |
Products named: Wegovy, BREZTRI, NURTEC ODT, CAPLYTA, AIRSUPRA, UBRELVY, REXULTI, Auvelity.
Industry payments across MI — which companies pay providers there.
